• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描(PET)重建对横断面和纵向分析中淀粉样蛋白-β定量的影响。

Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.

机构信息

Department of Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia.

Melbourne Brain Centre Imaging Unit, University of Melbourne, Melbourne, Victoria, Australia.

出版信息

J Nucl Med. 2024 May 1;65(5):781-787. doi: 10.2967/jnumed.123.266188.

DOI:10.2967/jnumed.123.266188
PMID:38575189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11064829/
Abstract

Amyloid-β (Aβ) accumulation in Alzheimer disease (AD) is typically measured using SUV ratio and the centiloid (CL) scale. The low spatial resolution of PET images is known to degrade quantitative metrics because of the partial-volume effect. This article examines the impact of spatial resolution, as determined by the reconstruction configuration, on the Aβ PET quantitation in both cross-sectional and longitudinal data. The cross-sectional study involved 89 subjects with 20-min [F]florbetapir scans generated on an mCT (44 Aβ-negative [Aβ-], 45 Aβ-positive [Aβ+]) using 69 reconstruction configurations, which varied in number of iteration updates, point-spread function, time-of-flight, and postreconstruction smoothing. The subjects were classified as Aβ- or Aβ+ visually. For each reconstruction, Aβ CL was calculated using CapAIBL, and the spatial resolution was calculated as full width at half maximum (FWHM) using the barrel phantom method. The change in CLs and the effect size of the difference in CLs between Aβ- and Aβ+ groups with FWHM were examined. The longitudinal study involved 79 subjects (46 Aβ-, 33 Aβ+) with three 20-min [F]flutemetamol scans generated on an mCT. The subjects were classified as Aβ- or Aβ+ using a cutoff CL of 20. All scans were reconstructed using low-, medium-, and high-resolution configurations, and Aβ CLs were calculated using CapAIBL. Since linear Aβ accumulation was assumed over a 10-y interval, for each reconstruction configuration, Aβ accumulation rate differences (ARDs) between the second and first periods were calculated for all subjects. Zero ARD was used as a consistency metric. The number of Aβ accumulators was also used to compare the sensitivity of CL across reconstruction configurations. In the cross-sectional study, CLs in both the Aβ- and the Aβ+ groups were impacted by the FWHM of the reconstruction method. Without postreconstruction smoothing, Aβ- CLs increased for a FWHM of 4.5 mm or more, whereas Aβ+ CLs decreased across the FWHM range. High-resolution reconstructions provided the best statistical separation between groups. In the longitudinal study, the median ARD of low-resolution reconstructed data for the Aβ- group was greater than zero whereas the ARDs of higher-resolution reconstructions were not significantly different from zero, indicating more consistent rate estimates in the higher-resolution reconstructions. Higher-resolution reconstructions identified 10 additional Aβ accumulators in the Aβ- group, resulting in a 22% increased group size compared with the low-resolution reconstructions. Higher-resolution reconstructions reduced the average CLs of the negative group by 12 points. High-resolution PET reconstructions, inherently less impacted by partial-volume effect, may improve Aβ PET quantitation in both cross-sectional and longitudinal data. In the cross-sectional analysis, separation of CLs between Aβ- and Aβ+ cohorts increased with spatial resolution. Higher-resolution reconstructions also exhibited both improved consistency and improved sensitivity in measures of Aβ accumulation. These features suggest that higher-resolution reconstructions may be advantageous in early-stage AD therapies.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/9a70fe1584b5/jnumed.123.266188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/1b6f5c9e6fa3/jnumed.123.266188absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/55252aef264f/jnumed.123.266188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/056e253b297c/jnumed.123.266188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/9a70fe1584b5/jnumed.123.266188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/1b6f5c9e6fa3/jnumed.123.266188absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/55252aef264f/jnumed.123.266188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/056e253b297c/jnumed.123.266188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13e5/11064829/9a70fe1584b5/jnumed.123.266188f3.jpg
摘要

淀粉样蛋白-β(Aβ)在阿尔茨海默病(AD)中的积累通常使用 SUV 比值和百分位(CL)量表来衡量。众所周知,由于部分容积效应,PET 图像的低空间分辨率会降低定量指标。本文研究了重建配置决定的空间分辨率对横断面和纵向数据中 Aβ PET 定量的影响。

在横断面研究中,89 名参与者进行了 20 分钟的[F]florbetapir 扫描,使用 69 种重建配置在 mCT 上生成(44 名 Aβ-阴性[Aβ-],45 名 Aβ-阳性[Aβ+]),这些配置在迭代更新、点扩散函数、飞行时间和后重建平滑方面各不相同。参与者根据视觉进行 Aβ-或 Aβ+分类。对于每种重建,使用 CapAIBL 计算 Aβ CL,并使用桶形幻影方法计算全宽半最大值(FWHM)作为空间分辨率。检查了 CL 的变化以及 Aβ-和 Aβ+组之间 CL 差异的效应大小与 FWHM 的关系。

在纵向研究中,79 名参与者(46 名 Aβ-,33 名 Aβ+)进行了三次 20 分钟的[F]flutemetamol 扫描,在 mCT 上生成。使用 20 的 CL 作为截止值对参与者进行 Aβ-或 Aβ+分类。所有扫描均使用低、中、高分辨率配置进行重建,并使用 CapAIBL 计算 Aβ CL。由于假定在 10 年的间隔内线性 Aβ 积累,对于每种重建配置,对所有参与者计算了第二和第一个时期之间的 Aβ 积累率差异(ARD)。零 ARD 用作一致性指标。还使用 Aβ 积累者的数量来比较不同重建配置的 CL 敏感性。

在横断面研究中,Aβ-和 Aβ+组的 CL 均受重建方法的 FWHM 影响。没有后重建平滑时,对于 FWHM 为 4.5mm 或更大的情况,Aβ- CL 会增加,而 Aβ+ CL 则会在整个 FWHM 范围内下降。高分辨率重建提供了最佳的组间统计学分离。在纵向研究中,Aβ-组低分辨率重建数据的中位 ARD 大于零,而高分辨率重建的 ARD 与零没有显著差异,表明高分辨率重建的速率估计更一致。高分辨率重建在 Aβ-组中发现了 10 个额外的 Aβ 积累者,与低分辨率重建相比,组大小增加了 22%。高分辨率重建将阴性组的平均 CL 降低了 12 分。

固有受部分容积效应影响较小的高分辨率 PET 重建,可能会提高横断面和纵向数据中 Aβ PET 定量的准确性。在横断面分析中,Aβ-和 Aβ+队列之间的 CL 分离随着空间分辨率的提高而增加。高分辨率重建还表现出改善的一致性和 Aβ 积累测量的敏感性。这些特征表明,高分辨率重建可能在早期 AD 治疗中具有优势。

相似文献

1
Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.正电子发射断层扫描(PET)重建对横断面和纵向分析中淀粉样蛋白-β定量的影响。
J Nucl Med. 2024 May 1;65(5):781-787. doi: 10.2967/jnumed.123.266188.
2
Inter-scanner Aβ-PET harmonization using barrel phantom spatial resolution matching.使用桶状体模空间分辨率匹配进行扫描仪间的淀粉样蛋白正电子发射断层显像(Aβ-PET)标准化
Alzheimers Dement (Amst). 2024 Mar 11;16(1):e12561. doi: 10.1002/dad2.12561. eCollection 2024 Jan-Mar.
3
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.β-淀粉样蛋白 PET 纵向研究的协调:在 AIBL、ADNI 和 OASIS3 中的应用。
Neuroimage. 2022 Nov 15;262:119527. doi: 10.1016/j.neuroimage.2022.119527. Epub 2022 Jul 30.
4
Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.使用18F-氟代贝他吡PET和标准化摄取值比率测量纵向β-淀粉样蛋白变化。
J Nucl Med. 2015 Apr;56(4):567-74. doi: 10.2967/jnumed.114.148981. Epub 2015 Mar 5.
5
Implementing the centiloid transformation for C-PiB and β-amyloid F-PET tracers using CapAIBL.使用 CapAIBL 实现 C-PiB 和 β-淀粉样蛋白 F-PET 示踪剂的百分位数转换。
Neuroimage. 2018 Dec;183:387-393. doi: 10.1016/j.neuroimage.2018.08.044. Epub 2018 Aug 18.
6
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.通过脑白质参考区域增强纵向淀粉样蛋白β正电子发射断层扫描(PET)变化特征描述及评估淀粉样蛋白修饰治疗的效能。
J Nucl Med. 2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5.
7
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
8
Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.阿尔茨海默病全病程中脑脊液与氟代硼吡咯 F-18 β-淀粉样蛋白测量值之间的非线性关联
JAMA Neurol. 2015 May;72(5):571-81. doi: 10.1001/jamaneurol.2014.4829.
9
Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.比较正电子发射断层扫描成像与β-淀粉样蛋白的脑脊液测量。
Ann Neurol. 2013 Dec;74(6):826-36. doi: 10.1002/ana.23908.
10
Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.差分百分位数尺度归一化技术:杂交 PET/MRI 与独立采集 MRI 的比较。
Ann Nucl Med. 2024 Oct;38(10):835-846. doi: 10.1007/s12149-024-01955-z. Epub 2024 Jun 20.

引用本文的文献

1
Evaluation of two clinical Centiloid analysis products for F-florbetapir PET in cognitively unimpaired elders.认知功能未受损老年人中两种用于氟代硼替吡(F-florbetapir)PET的临床半定量分析产品的评估
Alzheimers Dement (Amst). 2025 Aug 12;17(3):e70163. doi: 10.1002/dad2.70163. eCollection 2025 Jul-Sep.
2
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.阿尔茨海默病淀粉样蛋白PET和脑脊液生物标志物临床应用的考量
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.
3
Lecanemab approval in EU: what should we be ready for?- the EANM perspective.

本文引用的文献

1
Effect of Point Spread Function Deconvolution in Reconstruction of Brain F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease.点扩散函数去卷积在脑F-FDG PET图像重建中对阿尔茨海默病诊断思维效能的影响
Front Med (Lausanne). 2021 Jul 29;8:721551. doi: 10.3389/fmed.2021.721551. eCollection 2021.
2
Harmonisation of PET/CT contrast recovery performance for brain studies.脑研究中 PET/CT 对比恢复性能的协调。
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2856-2870. doi: 10.1007/s00259-021-05201-w. Epub 2021 Jan 31.
3
Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.
欧盟批准lecanemab:我们应做好哪些准备?——欧洲核医学协会的观点
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1607-1610. doi: 10.1007/s00259-025-07066-9.
4
Inter-scanner Aβ-PET harmonization using barrel phantom spatial resolution matching.使用桶状体模空间分辨率匹配进行扫描仪间的淀粉样蛋白正电子发射断层显像(Aβ-PET)标准化
Alzheimers Dement (Amst). 2024 Mar 11;16(1):e12561. doi: 10.1002/dad2.12561. eCollection 2024 Jan-Mar.
非负矩阵分解提高了 Centiloid 在纵向研究中的稳健性。
Neuroimage. 2021 Feb 1;226:117593. doi: 10.1016/j.neuroimage.2020.117593. Epub 2020 Nov 26.
4
Image reconstruction methods affect software-aided assessment of pathologies of [F]flutemetamol and [F]FDG brain-PET examinations in patients with neurodegenerative diseases.图像重建方法影响使用软件辅助评估神经退行性疾病患者 [F]氟替美莫和 [F]FDG 脑 PET 检查的病变情况。
Neuroimage Clin. 2020;28:102386. doi: 10.1016/j.nicl.2020.102386. Epub 2020 Aug 19.
5
Implementing the centiloid transformation for C-PiB and β-amyloid F-PET tracers using CapAIBL.使用 CapAIBL 实现 C-PiB 和 β-淀粉样蛋白 F-PET 示踪剂的百分位数转换。
Neuroimage. 2018 Dec;183:387-393. doi: 10.1016/j.neuroimage.2018.08.044. Epub 2018 Aug 18.
6
Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.使用置于倾斜角的圆柱体 phantom 测量 PET 空间分辨率。
J Nucl Med. 2018 Nov;59(11):1768-1775. doi: 10.2967/jnumed.118.209593. Epub 2018 Jun 14.
7
Phantom criteria for qualification of brain FDG and amyloid PET across different cameras.不同相机脑 FDG 和淀粉样蛋白 PET 资格认证的体模标准。
EJNMMI Phys. 2016 Dec;3(1):23. doi: 10.1186/s40658-016-0159-y. Epub 2016 Oct 6.
8
Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies.使用替代滤波策略时,点扩散函数建模和飞行时间对肺部病变中FDG摄取测量的影响。
EJNMMI Phys. 2014 Dec;1(1):99. doi: 10.1186/s40658-014-0099-3. Epub 2014 Nov 30.
9
Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.使用体模对脑部氟代脱氧葡萄糖(FDG)和淀粉样蛋白正电子发射断层扫描(PET)成像的图像重建条件进行优化。
Ann Nucl Med. 2016 Jan;30(1):18-28. doi: 10.1007/s12149-015-1024-0. Epub 2015 Sep 4.
10
The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.肿瘤与背景比值与 SUVmax 偏差与点扩散函数和飞行时间 F18-FDG-PET/CT 重建的关系在结直肠癌肝转移中的应用。
EJNMMI Res. 2015 May 6;5:31. doi: 10.1186/s13550-015-0111-5. eCollection 2015.